SC 13G Filing

Company

Whitehawk Therapeutics, Inc.

Filed

September 7, 2021

Accession Number

0000921895-21-002248

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →